San Jose

The San Jose SOCRA Chapter presents:


“Clinically Assessing Abnormalities: To AE, SAE, or Neither?”

Date: Thursday, March 9th, 2023
Time: 11:30-12:30pm PST
Location: Webinar – Online Only
Speaker: Jeannie Farnsworth, MS, BS, CCRP, MRQA

About the Speaker:
Jeannie is an Oncology Clinical Scientist who has been in the clinical research industry for over 22 years as a study coordinator, manager, contractor, consultant, and monitor working on both drug and device clinical trials, predominantly assisting sites with study startup, protocol procurement, trial operations and staff training. She has worked in a variety of settings across the research design process in both the public and private sector, across small and large institutions. She is currently working as a clinical scientist assisting the medical monitor in safety, while serving as the Senior Chapter Chair for the SOCRA Phoenix / Valley of the Sun chapter and as a board member of the SOCRA National Board.

Speaker’s Affiliations:
• ICON, on Assignment for Merck

• To better understand of assessment abnormalities against the subject’s overall health and impact on study outcome(s)
• To gain better clarity on “clinically significant” vs “not clinically significant” abnormalities
• To appreciate how and when abnormalities should be considered AEs or SAEs

*Please RSVP to receive Conference Call Details

SOCRA CEUs available: 1 (for SOCRA members)

Questions: Please contact Allie Mossing (408-470-1056;


Chapter Chairperson:

Allie Mossing
Phone: 408 470 1079